{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:05:11Z","timestamp":1794049511009,"version":"4.8.0"},"reference-count":258,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Hubei Province,China","award":["2025AFB117"],"award-info":[{"award-number":["2025AFB117"]}]},{"name":"Natural Science Foundation of Hubei Province,China","award":["2024AFD272"],"award-info":[{"award-number":["2024AFD272"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82105009"],"award-info":[{"award-number":["82105009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374585"],"award-info":[{"award-number":["82374585"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82305303"],"award-info":[{"award-number":["82305303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02557-7","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:34:32Z","timestamp":1769052872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cancer stem cell-driven drug resistance in colorectal carcinoma: molecular aspects and therapeutic potentials"],"prefix":"10.1186","volume":"25","author":[{"given":"Minfeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guichen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minquan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxia","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"2557_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325:669\u201385.","journal-title":"JAMA"},{"key":"2557_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.annonc.2024.11.012","volume":"36","author":"T Andre","year":"2025","unstructured":"Andre T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt CJA, et al. Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study. Ann Oncol. 2025;36:277\u201384.","journal-title":"Ann Oncol"},{"key":"2557_CR3","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.cgh.2024.11.019","volume":"23","author":"L Guo","year":"2025","unstructured":"Guo L, Wang L, Cai L, Zhang Y, Feng X, Zhu C, et al. Global distribution of colorectal cancer staging at diagnosis: an evidence synthesis. Clin Gastroenterol Hepatol. 2025;23:2088\u2013101.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2557_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.101015","volume":"6","author":"T Maklin","year":"2025","unstructured":"Maklin T, Taira A, Arredondo-Alonso S, Shao Y, Stratton MR, Lawley TD, et al. Geographical variation in the incidence of colorectal cancer and urinary tract cancer is associated with population exposure to colibactin-producing Escherichia coli. Lancet Microbe. 2025;6:101015.","journal-title":"Lancet Microbe"},{"key":"2557_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41392-025-02229-4","volume":"10","author":"Y Shi","year":"2025","unstructured":"Shi Y, Ba Y, Wang J, Xiong J, Gu K, Chen Y, Zheng Z, Wang Z, Guo W, Cheng Y, et al. First-line treatment of anti-EGFR monoclonal antibody cetuximab beta plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS\/BRAF wild-type metastatic colorectal cancer: a randomized, phase 3 trial. Signal Transduct Target Ther. 2025;10:147.","journal-title":"Signal Transduct Target Ther"},{"key":"2557_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","volume":"21","author":"M Schmitt","year":"2021","unstructured":"Schmitt M, Greten FR. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol. 2021;21:653\u201367.","journal-title":"Nat Rev Immunol"},{"key":"2557_CR7","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2557_CR8","doi-asserted-by":"crossref","unstructured":"Brockmueller A, Girisa S, Kunnumakkara AB, Shakibaei M. Resveratrol modulates chemosensitisation to 5-FU via beta1-Integrin\/HIF-1alpha axis in CRC tumor microenvironment. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms24054988"},{"key":"2557_CR9","unstructured":"Ohba A, Ozaka M, Mizusawa J, Okusaka T, Kobayashi S, Yamashita T, Ikeda M, Yasuda I, Sugimori K, Sasahira N et al. Modified Fluorouracil, Leucovorin, Irinotecan, and oxaliplatin or S-1, Irinotecan, and oxaliplatin versus Nab-Paclitaxel\u2009+\u2009Gemcitabine in metastatic or recurrent pancreatic cancer (GENERATE, JCOG1611): A Randomized, Open-Label, phase II\/III trial. J Clin Oncol. 2025;JCO2400936."},{"key":"2557_CR10","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1200\/JCO.23.02659","volume":"42","author":"PA Philip","year":"2024","unstructured":"Philip PA, Sahai V, Bahary N, Mahipal A, Kasi A, Rocha Lima CMS, et al. Devimistat (CPI-613) with modified fluorouarcil, oxaliplatin, irinotecan, and leucovorin (FFX) versus FFX for patients with metastatic adenocarcinoma of the pancreas: the phase III AVENGER 500 study. J Clin Oncol. 2024;42:3692\u2013701.","journal-title":"J Clin Oncol"},{"key":"2557_CR11","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1200\/JCO-24-01378","volume":"43","author":"L Schwarz","year":"2025","unstructured":"Schwarz L, Bachet JB, Meurisse A, Bouche O, Assenat E, Piessen G, Hammel P, Regenet N, Taieb J, Turrini O, et al. Neoadjuvant FOLF(IRIN)OX chemotherapy for resectable pancreatic adenocarcinoma: A multicenter randomized noncomparative phase II trial (PANACHE01 FRENCH08 PRODIGE48 study). J Clin Oncol. 2025;43:1984\u201396.","journal-title":"J Clin Oncol"},{"key":"2557_CR12","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1038\/s41591-024-03235-9","volume":"30","author":"S Kopetz","year":"2024","unstructured":"Kopetz S, Murphy DA, Pu J, Ciardiello F, Desai J, Van Cutsem E, et al. Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial. Nat Med. 2024;30:3261\u201371.","journal-title":"Nat Med"},{"key":"2557_CR13","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41586-024-08150-0","volume":"637","author":"A Moorman","year":"2025","unstructured":"Moorman A, Benitez EK, Cambulli F, Jiang Q, Mahmoud A, Lumish M, et al. Progressive plasticity during colorectal cancer metastasis. Nature. 2025;637:947\u201354.","journal-title":"Nature"},{"key":"2557_CR14","volume":"6","author":"S Li","year":"2025","unstructured":"Li S, Zhao W, An Q, Wang L, Zhu M, Ni J, et al. Novel cancer stem cell-targeted retinoid ZSH-512 impedes colorectal cancer progress via KDM3A-mediated epigenetic reprogramming. Innovation. 2025;6:100831.","journal-title":"Innovation"},{"key":"2557_CR15","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1158\/1078-0432.CCR-13-0634","volume":"19","author":"DC Singleton","year":"2013","unstructured":"Singleton DC, Harris AL. Microenvironmental induced essentiality of autophagy. Clin Cancer Res. 2013;19:2791\u20133.","journal-title":"Clin Cancer Res"},{"key":"2557_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01294-4","volume":"15","author":"J Weng","year":"2022","unstructured":"Weng J, Li S, Zhu Z, Liu Q, Zhang R, Yang Y, et al. Exploring immunotherapy in colorectal cancer. J Hematol Oncol. 2022;15:95.","journal-title":"J Hematol Oncol"},{"key":"2557_CR17","volume":"1876","author":"M Luo","year":"2021","unstructured":"Luo M, Yang X, Chen HN, Nice EC, Huang C. Drug resistance in colorectal cancer: an epigenetic overview. Biochimica et Biophysica Acta (BBA). 2021;1876:188623.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"2557_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100796","volume":"59","author":"R Nussinov","year":"2021","unstructured":"Nussinov R, Tsai CJ, Jang H. Anticancer drug resistance: an update and perspective. Drug Resist Updat. 2021;59:100796.","journal-title":"Drug Resist Updat"},{"key":"2557_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41571-023-00834-2","volume":"21","author":"L Yang","year":"2024","unstructured":"Yang L, Yang J, Kleppe A, Danielsen HE, Kerr DJ. Personalizing adjuvant therapy for patients with colorectal cancer. Nat Rev Clin Oncol. 2024;21:67\u201379.","journal-title":"Nat Rev Clin Oncol"},{"key":"2557_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41576-023-00649-y","volume":"25","author":"SP Djordjevic","year":"2024","unstructured":"Djordjevic SP, Jarocki VM, Seemann T, Cummins ML, Watt AE, Drigo B, Wyrsch ER, Reid CJ, Donner E, Howden BP. Genomic surveillance for antimicrobial resistance - a one health perspective. Nat Rev Genet. 2024;25:142\u201357.","journal-title":"Nat Rev Genet"},{"key":"2557_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.trecan.2023.11.003","volume":"10","author":"CJ Tape","year":"2024","unstructured":"Tape CJ. Plastic persisters: revival stem cells in colorectal cancer. Trends Cancer. 2024;10:185\u201395.","journal-title":"Trends Cancer"},{"key":"2557_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1146\/annurev-pathmechdis-031521-041113","volume":"18","author":"JC Sedlak","year":"2023","unstructured":"Sedlak JC, Yilmaz OH, Roper J. Metabolism and colorectal cancer. Annu Rev Pathol. 2023;18:467\u201392.","journal-title":"Annu Rev Pathol"},{"key":"2557_CR23","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.stem.2022.07.008","volume":"29","author":"EG Vasquez","year":"2022","unstructured":"Vasquez EG, Nasreddin N, Valbuena GN, Mulholland EJ, Belnoue-Davis HL, Eggington HR, Schenck RO, Wouters VM, Wirapati P, Gilroy K, et al. Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia. Cell Stem Cell. 2022;29:1213\u2013e12281218.","journal-title":"Cell Stem Cell"},{"key":"2557_CR24","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1053\/j.gastro.2020.12.080","volume":"160","author":"MH Frank","year":"2021","unstructured":"Frank MH, Wilson BJ, Gold JS, Frank NY. Clinical implications of colorectal cancer stem cells in the age of single-cell omics and targeted therapies. Gastroenterology. 2021;160:1947\u201360.","journal-title":"Gastroenterology"},{"key":"2557_CR25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s43018-023-00715-8","volume":"5","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu J, Cheng Q, Zhang Q, Zhang Y, Jiang L, et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat Cancer. 2024;5:572\u201389.","journal-title":"Nat Cancer"},{"key":"2557_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004320","volume":"8","author":"H Wang","year":"2021","unstructured":"Wang H, Gong P, Chen T, Gao S, Wu Z, Wang X, et al. Colorectal cancer stem cell states uncovered by simultaneous single-cell analysis of transcriptome and telomeres. Adv Sci. 2021;8:2004320.","journal-title":"Adv Sci"},{"key":"2557_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100759","volume":"8","author":"Z Yu","year":"2021","unstructured":"Yu Z, Deng P, Chen Y, Liu S, Chen J, Yang Z, et al. Inhibition of the PLK1-coupled cell cycle machinery overcomes resistance to oxaliplatin in colorectal cancer. Adv Sci. 2021;8:e2100759.","journal-title":"Adv Sci"},{"key":"2557_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.semcancer.2020.02.011","volume":"80","author":"W Weng","year":"2022","unstructured":"Weng W, Goel A. Curcumin and colorectal cancer: an update and current perspective on this natural medicine. Semin Cancer Biol. 2022;80:73\u201386.","journal-title":"Semin Cancer Biol"},{"key":"2557_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13287-022-02913-0","volume":"13","author":"H Zheng","year":"2022","unstructured":"Zheng H, Liu H, Li H, Dou W, Wang J, Zhang J, Liu T, Wu Y, Liu Y, Wang X. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer. Stem Cell Res Ther. 2022;13:244.","journal-title":"Stem Cell Res Ther"},{"key":"2557_CR30","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.annonc.2023.05.010","volume":"34","author":"T Ratovomanana","year":"2023","unstructured":"Ratovomanana T, Nicolle R, Cohen R, Diehl A, Siret A, Letourneur Q, et al. Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability. Ann Oncol. 2023;34:703\u201313.","journal-title":"Ann Oncol"},{"key":"2557_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100963","volume":"69","author":"H Saeed","year":"2023","unstructured":"Saeed H, Leibowitz BJ, Zhang L, Yu J. Targeting Myc-driven stress addiction in colorectal cancer. Drug Resist Updat. 2023;69:100963.","journal-title":"Drug Resist Updat"},{"key":"2557_CR32","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1111\/bph.15422","volume":"178","author":"SY Sun","year":"2021","unstructured":"Sun SY, Hu XT, Yu XF, Zhang YY, Liu XH, Liu YH, Wu SH, Li YY, Cui SX, Qu XJ. Nuclear translocation of ATG5 induces DNA mismatch repair deficiency (MMR-D)\/microsatellite instability (MSI) via interacting with Mis18alpha in colorectal cancer. Br J Pharmacol. 2021;178:2351\u201369.","journal-title":"Br J Pharmacol"},{"key":"2557_CR33","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1053\/j.gastro.2020.08.018","volume":"159","author":"B Chen","year":"2020","unstructured":"Chen B, Dragomir MP, Fabris L, Bayraktar R, Knutsen E, Liu X, Tang C, Li Y, Shimura T, Ivkovic TC, et al. The long noncoding RNA CCAT2 induces chromosomal instability through BOP1-AURKB signaling. Gastroenterology. 2020;159:2146\u2013e21622133.","journal-title":"Gastroenterology"},{"key":"2557_CR34","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1126\/science.aav4474","volume":"366","author":"M Russo","year":"2019","unstructured":"Russo M, Crisafulli G, Sogari A, Reilly NM, Arena S, Lamba S, et al. Adaptive mutability of colorectal cancers in response to targeted therapies. Science. 2019;366:1473\u201380.","journal-title":"Science"},{"key":"2557_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35096-6","volume":"13","author":"Q Sui","year":"2022","unstructured":"Sui Q, Zhang X, Chen C, Tang J, Yu J, Li W, et al. Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer. Nat Commun. 2022;13:7316.","journal-title":"Nat Commun"},{"key":"2557_CR36","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1200\/JCO.21.02691","volume":"40","author":"Z Jin","year":"2022","unstructured":"Jin Z, Sinicrope FA. Mismatch repair-deficient colorectal cancer: building on checkpoint blockade. J Clin Oncol. 2022;40:2735\u201350.","journal-title":"J Clin Oncol"},{"key":"2557_CR37","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/cncr.35267","volume":"130","author":"YL Liu","year":"2024","unstructured":"Liu YL, Weigelt B. A tale of two pathways: review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers. Cancer. 2024;130:1733\u201346.","journal-title":"Cancer"},{"key":"2557_CR38","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1158\/1541-7786.MCR-20-0308","volume":"18","author":"E Endo","year":"2020","unstructured":"Endo E, Okayama H, Saito K, Nakajima S, Yamada L, Ujiie D, Kase K, Fujita S, Endo H, Sakamoto W, et al. A TGFbeta-Dependent stromal subset underlies immune checkpoint inhibitor efficacy in DNA mismatch Repair-Deficient\/Microsatellite Instability-High colorectal cancer. Mol Cancer Res. 2020;18:1402\u201313.","journal-title":"Mol Cancer Res"},{"key":"2557_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-021-00870-z","volume":"22","author":"F Pecci","year":"2021","unstructured":"Pecci F, Cantini L, Bittoni A, Lenci E, Lupi A, Crocetti S, et al. Beyond microsatellite instability: evolving strategies integrating immunotherapy for microsatellite stable colorectal cancer. Curr Treat Options Oncol. 2021;22:69.","journal-title":"Curr Treat Options Oncol"},{"key":"2557_CR40","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1158\/1078-0432.CCR-20-3635","volume":"27","author":"H Arai","year":"2021","unstructured":"Arai H, Elliott A, Xiu J, Wang J, Battaglin F, Kawanishi N, et al. The landscape of alterations in DNA damage response pathways in colorectal cancer. Clin Cancer Res. 2021;27:3234\u201342.","journal-title":"Clin Cancer Res"},{"key":"2557_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejca.2022.07.020","volume":"175","author":"J Taieb","year":"2022","unstructured":"Taieb J, Svrcek M, Cohen R, Basile D, Tougeron D, Phelip JM. Deficient mismatch repair\/microsatellite unstable colorectal cancer: diagnosis, prognosis and treatment. Eur J Cancer. 2022;175:136\u201357.","journal-title":"Eur J Cancer"},{"key":"2557_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.953421","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Hu J, Zhang Y, Li L, Wang T, Qian X. Case report: a colorectal cancer patient with microsatellite instability-high and MSH2 germline mutation failed to respond to anti-PD-1 immunotherapy. Front Immunol. 2022;13:953421.","journal-title":"Front Immunol"},{"key":"2557_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308690","volume":"11","author":"R Hosea","year":"2024","unstructured":"Hosea R, Duan W, Meliala ITS, Li W, Wei M, Hillary S, et al. YY2\/BUB3 axis promotes SAC hyperactivation and inhibits colorectal cancer progression via regulating chromosomal instability. Adv Sci. 2024;11:e2308690.","journal-title":"Adv Sci"},{"key":"2557_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01581-1","volume":"21","author":"J Chou","year":"2022","unstructured":"Chou J, Kaller M, Jaeckel S, Rokavec M, Hermeking H. AP4 suppresses DNA damage, chromosomal instability and senescence via inducing MDC1\/Mediator of DNA damage Checkpoint 1 and repressing MIR22HG\/miR-22-3p. Mol Cancer. 2022;21:120.","journal-title":"Mol Cancer"},{"key":"2557_CR45","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1158\/1078-0432.CCR-23-4005","volume":"30","author":"E Harrold","year":"2024","unstructured":"Harrold E, Keane F, Walch H, Chou JF, Sinopoli J, Palladino S, et al. Molecular and clinical determinants of acquired resistance and treatment duration for targeted therapies in colorectal cancer. Clin Cancer Res. 2024;30:2672\u201383.","journal-title":"Clin Cancer Res"},{"key":"2557_CR46","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1038\/s41401-024-01372-y","volume":"45","author":"X Fang","year":"2024","unstructured":"Fang X, Yu WY, Zhu CM, Zhao N, Zhao W, Xie TT, Wei LJ, Sun XR, Xie J, Zhao Y. Chromosome instability functions as a potential therapeutic reference by enhancing chemosensitivity to BCL-XL inhibitors in colorectal carcinoma. Acta Pharmacol Sin. 2024;45:2420\u201331.","journal-title":"Acta Pharmacol Sin"},{"key":"2557_CR47","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.1002\/cam4.5325","volume":"12","author":"X Lai","year":"2023","unstructured":"Lai X, Yu R, Ou Q, Bao H, Wu X, Shao Y, Li Y, Zhang Y, Ding Q. Clinical and molecular characteristics of kinase domain duplications across diverse cancer types in the Chinese population. Cancer Med. 2023;12:6009\u201315.","journal-title":"Cancer Med"},{"key":"2557_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0965-7","volume":"18","author":"S Maacha","year":"2019","unstructured":"Maacha S, Bhat AA, Jimenez L, Raza A, Haris M, Uddin S, et al. Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance. Mol Cancer. 2019;18:55.","journal-title":"Mol Cancer"},{"key":"2557_CR49","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","volume":"54","author":"D Barkley","year":"2022","unstructured":"Barkley D, Moncada R, Pour M, Liberman DA, Dryg I, Werba G, et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat Genet. 2022;54:1192\u2013201.","journal-title":"Nat Genet"},{"key":"2557_CR50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","volume":"41","author":"O Elhanani","year":"2023","unstructured":"Elhanani O, Ben-Uri R, Keren L. Spatial profiling technologies illuminate the tumor microenvironment. Cancer Cell. 2023;41:404\u201320.","journal-title":"Cancer Cell"},{"key":"2557_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1019-x","volume":"18","author":"JL Hu","year":"2019","unstructured":"Hu JL, Wang W, Lan XL, Zeng ZC, Liang YS, Yan YR, et al. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Mol Cancer. 2019;18:91.","journal-title":"Mol Cancer"},{"key":"2557_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36334-1","volume":"14","author":"J Linares","year":"2023","unstructured":"Linares J, Sallent-Aragay A, Badia-Ramentol J, Recort-Bascuas A, Mendez A, Manero-Ruperez N, et al. Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nat Commun. 2023;14:746.","journal-title":"Nat Commun"},{"key":"2557_CR53","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1021\/acs.jproteome.4c00112","volume":"23","author":"R Lau","year":"2024","unstructured":"Lau R, Yu L, Roumeliotis TI, Stewart A, Pickard L, Choudhary JS, et al. Secretome of cancer-associated fibroblasts (CAFs) influences drug sensitivity in cancer cells. J Proteome Res. 2024;23:2160\u20138.","journal-title":"J Proteome Res"},{"key":"2557_CR54","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ccell.2020.05.005","volume":"37","author":"Y Shen","year":"2020","unstructured":"Shen Y, Wang X, Lu J, Salfenmoser M, Wirsik NM, Schleussner N, Imle A, Freire Valls A, Radhakrishnan P, Liang J, et al. Reduction of liver metastasis stiffness improves response to bevacizumab in metastatic colorectal cancer. Cancer Cell. 2020;37:800\u2013e817807.","journal-title":"Cancer Cell"},{"key":"2557_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101125","volume":"77","author":"D Dong","year":"2024","unstructured":"Dong D, Yu X, Xu J, Yu N, Liu Z, Sun Y. Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance. Drug Resist Updat. 2024;77:101125.","journal-title":"Drug Resist Updat"},{"key":"2557_CR56","doi-asserted-by":"publisher","first-page":"12127","DOI":"10.7150\/thno.52450","volume":"10","author":"H Chen","year":"2020","unstructured":"Chen H, Cheng Y, Wang X, Wang J, Shi X, Li X, Tan W, Tan Z. 3D printed in vitro tumor tissue model of colorectal cancer. Theranostics. 2020;10:12127\u201343.","journal-title":"Theranostics"},{"key":"2557_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119676","volume":"232","author":"S Ma","year":"2020","unstructured":"Ma S, Song W, Xu Y, Si X, Zhang D, Lv S, et al. Neutralizing tumor-promoting inflammation with polypeptide-dexamethasone conjugate for microenvironment modulation and colorectal cancer therapy. Biomaterials. 2020;232:119676.","journal-title":"Biomaterials"},{"key":"2557_CR58","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1016\/j.ymthe.2021.04.028","volume":"29","author":"T Ning","year":"2021","unstructured":"Ning T, Li J, He Y, Zhang H, Wang X, Deng T, et al. Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer. Mol Ther. 2021;29:2723\u201336.","journal-title":"Mol Ther"},{"key":"2557_CR59","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","volume":"40","author":"Q Shi","year":"2022","unstructured":"Shi Q, Shen Q, Liu Y, Shi Y, Huang W, Wang X, Li Z, Chai Y, Wang H, Hu X, et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal cathepsin B to promote cancer metastasis and chemoresistance. Cancer Cell. 2022;40:1207\u2013e12221210.","journal-title":"Cancer Cell"},{"key":"2557_CR60","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.1158\/1078-0432.CCR-17-1283","volume":"23","author":"Y Yin","year":"2017","unstructured":"Yin Y, Yao S, Hu Y, Feng Y, Li M, Bian Z, et al. The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL6. Clin Cancer Res. 2017;23:7375\u201387.","journal-title":"Clin Cancer Res"},{"key":"2557_CR61","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41388-019-0999-8","volume":"39","author":"TT Wei","year":"2020","unstructured":"Wei TT, Lin YT, Tang SP, Luo CK, Tsai CT, Shun CT, Chen CC. Metabolic targeting of HIF-1alpha potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer. Oncogene. 2020;39:414\u201327.","journal-title":"Oncogene"},{"key":"2557_CR62","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/med.21452","volume":"37","author":"R Ronca","year":"2017","unstructured":"Ronca R, Benkheil M, Mitola S, Struyf S, Liekens S. Tumor angiogenesis revisited: regulators and clinical implications. Med Res Rev. 2017;37:1231\u201374.","journal-title":"Med Res Rev"},{"key":"2557_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10456-019-09698-6","volume":"23","author":"EA Kuczynski","year":"2020","unstructured":"Kuczynski EA, Reynolds AR. Vessel co-option and resistance to anti-angiogenic therapy. Angiogenesis. 2020;23:55\u201374.","journal-title":"Angiogenesis"},{"key":"2557_CR64","doi-asserted-by":"publisher","first-page":"10313","DOI":"10.1021\/acsnano.3c00668","volume":"17","author":"C Huang","year":"2023","unstructured":"Huang C, Zhou Y, Feng X, Wang J, Li Y, Yao X. Delivery of engineered primary tumor-derived exosomes effectively suppressed the colorectal cancer chemoresistance and liver metastasis. ACS Nano. 2023;17:10313\u201326.","journal-title":"ACS Nano"},{"key":"2557_CR65","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, Ren L, Li S, Li W, Zheng X, Yang Y, Fu W, Yi J, Wang J, Du G. The biology, function, and applications of exosomes in cancer. Acta Pharm Sin B. 2021;11:2783\u201397.","journal-title":"Acta Pharm Sin B"},{"key":"2557_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032061","author":"SAR Sancha","year":"2023","unstructured":"Sancha SAR, Szemeredi N, Spengler G, Ferreira MU. Lycorine carbamate derivatives for reversing P-glycoprotein-mediated multidrug resistance in human colon adenocarcinoma cells. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032061.","journal-title":"Int J Mol Sci"},{"key":"2557_CR67","doi-asserted-by":"crossref","unstructured":"Mosca L, Pagano M, Borzacchiello L, Mele L, Russo A, Russo G, Cacciapuoti G, Porcelli M. S-Adenosylmethionine increases the sensitivity of human colorectal cancer cells to 5-Fluorouracil by inhibiting P-Glycoprotein expression and NF-kappaB activation. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22179286"},{"key":"2557_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173138","volume":"880","author":"X Shi","year":"2020","unstructured":"Shi X, Valizadeh A, Mir SM, Asemi Z, Karimian A, Majidina M, et al. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells. Eur J Pharmacol. 2020;880:173138.","journal-title":"Eur J Pharmacol"},{"key":"2557_CR69","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1158\/1541-7786.MCR-20-0462","volume":"19","author":"M Bauzone","year":"2021","unstructured":"Bauzone M, Souidi M, Dessein AF, Wisztorski M, Vincent A, Gimeno JP, et al. Cross-talk between YAP and RAR-RXR drives expression of stemness genes to promote 5-FU resistance and self-renewal in colorectal cancer cells. Mol Cancer Res. 2021;19:612\u201322.","journal-title":"Mol Cancer Res"},{"key":"2557_CR70","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/cac2.12235","volume":"41","author":"VR Silva","year":"2021","unstructured":"Silva VR, Santos LS, Dias RB, Quadros CA, Bezerra DP. Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells. Cancer Commun (Lond). 2021;41:1275\u2013313.","journal-title":"Cancer Commun (Lond)"},{"key":"2557_CR71","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.7150\/thno.70754","volume":"12","author":"S Ghosh","year":"2022","unstructured":"Ghosh S, Singh R, Vanwinkle ZM, Guo H, Vemula PK, Goel A, Haribabu B, Jala VR. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis. Theranostics. 2022;12:5574\u201395.","journal-title":"Theranostics"},{"key":"2557_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01819-0","volume":"21","author":"M Pei","year":"2023","unstructured":"Pei M, Liu K, Qu X, Wang K, Chen Q, Zhang Y, et al. Enzyme-catalyzed synthesis of selenium-doped manganese phosphate for synergistic therapy of drug-resistant colorectal cancer. J Nanobiotechnology. 2023;21:72.","journal-title":"J Nanobiotechnology"},{"key":"2557_CR73","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.biopha.2014.10.019","volume":"68","author":"Z Kozovska","year":"2014","unstructured":"Kozovska Z, Gabrisova V, Kucerova L. Colon cancer: cancer stem cells markers, drug resistance and treatment. Biomed Pharmacother. 2014;68:911\u20136.","journal-title":"Biomed Pharmacother"},{"key":"2557_CR74","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/cas.14253","volume":"111","author":"H Wang","year":"2020","unstructured":"Wang H, Li JM, Wei W, Yang R, Chen D, Ma XD, Jiang GM, Wang BL. Regulation of ATP-binding cassette subfamily B member 1 by snail contributes to chemoresistance in colorectal cancer. Cancer Sci. 2020;111:84\u201397.","journal-title":"Cancer Sci"},{"key":"2557_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.109295","volume":"332","author":"T Matsunaga","year":"2020","unstructured":"Matsunaga T, Okumura N, Saito H, Morikawa Y, Suenami K, Hisamatsu A, et al. Significance of aldo-keto reductase 1C3 and ATP-binding cassette transporter B1 in gain of irinotecan resistance in colon cancer cells. Chem Biol Interact. 2020;332:109295.","journal-title":"Chem Biol Interact"},{"key":"2557_CR76","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41416-020-0783-0","volume":"122","author":"Z Yuan","year":"2020","unstructured":"Yuan Z, Liang X, Zhan Y, Wang Z, Xu J, Qiu Y, Wang J, Cao Y, Le VM, Ly HT, et al. Targeting CD133 reverses drug-resistance via the AKT\/NF-kappaB\/MDR1 pathway in colorectal cancer. Br J Cancer. 2020;122:1342\u201353.","journal-title":"Br J Cancer"},{"key":"2557_CR77","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature11156","volume":"486","author":"S Misale","year":"2012","unstructured":"Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature. 2012;486:532\u20136.","journal-title":"Nature"},{"key":"2557_CR78","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1053\/j.gastro.2020.08.016","volume":"159","author":"CC Wong","year":"2020","unstructured":"Wong CC, Xu J, Bian X, Wu JL, Kang W, Qian Y, Li W, Chen H, Gou H, Liu D, et al. In colorectal cancer cells with mutant KRAS, SLC25A22-Mediated Glutaminolysis reduces DNA demethylation to increase WNT Signaling, Stemness, and drug resistance. Gastroenterology. 2020;159:2163\u2013e21802166.","journal-title":"Gastroenterology"},{"key":"2557_CR79","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1158\/2159-8290.CD-21-1331","volume":"12","author":"MH Hofmann","year":"2022","unstructured":"Hofmann MH, Gerlach D, Misale S, Petronczki M, Kraut N. Expanding the reach of precision oncology by drugging all KRAS mutants. Cancer Discov. 2022;12:924\u201337.","journal-title":"Cancer Discov"},{"key":"2557_CR80","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature24673","volume":"552","author":"G Germano","year":"2017","unstructured":"Germano G, Lamba S, Rospo G, Barault L, Magri A, Maione F, et al. Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth. Nature. 2017;552:116\u201320.","journal-title":"Nature"},{"key":"2557_CR81","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0959-8049(99)00314-7","volume":"36","author":"A Sobrero","year":"2000","unstructured":"Sobrero A, Kerr D, Glimelius B, Van Cutsem E, Milano G, Pritchard DM, et al. New directions in the treatment of colorectal cancer: a look to the future. Eur J Cancer. 2000;36:559\u201366.","journal-title":"Eur J Cancer"},{"key":"2557_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100883","volume":"65","author":"LF Ye","year":"2022","unstructured":"Ye LF, Huang ZY, Chen XX, Chen ZG, Wu SX, Ren C, et al. Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA. Drug Resist Updat. 2022;65:100883.","journal-title":"Drug Resist Updat"},{"key":"2557_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.101935","volume":"82","author":"F Pietrantonio","year":"2020","unstructured":"Pietrantonio F, Randon G, Romagnoli D, Di Donato S, Benelli M, de Braud F. Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer. Cancer Treat Rev. 2020;82:101935.","journal-title":"Cancer Treat Rev"},{"key":"2557_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081295","author":"KM Mahmud","year":"2021","unstructured":"Mahmud KM, Niloy MS, Shakil MS, Islam MA. Ruthenium complexes: an alternative to platinum drugs in colorectal cancer treatment. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13081295.","journal-title":"Pharmaceutics"},{"key":"2557_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403485","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Li L, Wang X, Zhao F, Yang Y, Zhou Y, et al. USP25 elevates SHLD2-mediated DNA double-strand break repair and regulates chemoresponse in cancer. Adv Sci. 2024;11:e2403485.","journal-title":"Adv Sci"},{"key":"2557_CR86","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S2468-1253(22)00439-3","volume":"8","author":"G Chen","year":"2023","unstructured":"Chen G, Jin Y, Guan WL, Zhang RX, Xiao WW, Cai PQ, et al. Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study. Lancet Gastroenterol Hepatol. 2023;8:422\u201331.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2557_CR87","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.apsb.2021.02.008","volume":"11","author":"H Zhang","year":"2021","unstructured":"Zhang H, Fu L. The role of ALDH2 in tumorigenesis and tumor progression: targeting ALDH2 as a potential cancer treatment. Acta Pharm Sin B. 2021;11:1400\u201311.","journal-title":"Acta Pharm Sin B"},{"key":"2557_CR88","doi-asserted-by":"publisher","first-page":"e00149","DOI":"10.14309\/ctg.0000000000000149","volume":"11","author":"M Lee","year":"2020","unstructured":"Lee M, Eng G, Barbari SR, Deshpande V, Shcherbakova PV, Gala MK. Homologous recombination repair truncations predict hypermutation in microsatellite stable colorectal and endometrial tumors. Clin Transl Gastroenterol. 2020;11:e00149.","journal-title":"Clin Transl Gastroenterol"},{"key":"2557_CR89","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/s41388-023-02657-y","volume":"42","author":"X Zhang","year":"2023","unstructured":"Zhang X, Ma D, Xuan B, Shi D, He J, Yu M, et al. LncRNA cacclnc promotes chemoresistance of colorectal cancer by modulating alternative splicing of RAD51. Oncogene. 2023;42:1374\u201391.","journal-title":"Oncogene"},{"key":"2557_CR90","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1158\/0008-5472.CAN-22-4017","volume":"83","author":"M Wei","year":"2023","unstructured":"Wei M, Huang X, Liao L, Tian Y, Zheng X. SENP1 decreases RNF168 phase separation to promote DNA damage repair and drug resistance in colon cancer. Cancer Res. 2023;83:2908\u201323.","journal-title":"Cancer Res"},{"key":"2557_CR91","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/1878-0261.12965","volume":"15","author":"R Sreekumar","year":"2021","unstructured":"Sreekumar R, Al-Saihati H, Emaduddin M, Moutasim K, Mellone M, Patel A, et al. The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer. Mol Oncol. 2021;15:2065\u201383.","journal-title":"Mol Oncol"},{"key":"2557_CR92","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1158\/1535-7163.MCT-19-0600","volume":"19","author":"H Song","year":"2020","unstructured":"Song H, Zeng J, Roychoudhury S, Biswas P, Mohapatra B, Ray S, Dowlatshahi K, Wang J, Band V, Talmon G, Bhakat KK. Targeting histone chaperone FACT complex overcomes 5-Fluorouracil resistance in colon cancer. Mol Cancer Ther. 2020;19:258\u201369.","journal-title":"Mol Cancer Ther"},{"key":"2557_CR93","doi-asserted-by":"crossref","unstructured":"Das T, Anand U, Pandey SK, Ashby CR Jr., Assaraf YG, Chen ZS, et al. Therapeutic strategies to overcome taxane resistance in cancer. Drug Resist Updat. 2021;55:100754.","DOI":"10.1016\/j.drup.2021.100754"},{"key":"2557_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01626-6","volume":"22","author":"OA Sukocheva","year":"2024","unstructured":"Sukocheva OA, Neganova ME, Aleksandrova Y, Burcher JT, Chugunova E, Fan R, et al. Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-alpha immunotherapy. Cell Commun Signal. 2024;22:251.","journal-title":"Cell Commun Signal"},{"key":"2557_CR95","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.canlet.2020.08.019","volume":"494","author":"A Murphy","year":"2020","unstructured":"Murphy A, Costa M. Nuclear protein 1 imparts oncogenic potential and chemotherapeutic resistance in cancer. Cancer Lett. 2020;494:132\u201341.","journal-title":"Cancer Lett"},{"key":"2557_CR96","doi-asserted-by":"crossref","unstructured":"Buhrmann C, Kunnumakkara AB, Popper B, Majeed M, Aggarwal BB, Shakibaei M. Calebin A potentiates the effect of 5-FU and TNF-beta (Lymphotoxin alpha) against human colorectal cancer cells: potential role of NF-kappaB. Int J Mol Sci. 2020;21.","DOI":"10.3390\/ijms21072393"},{"key":"2557_CR97","doi-asserted-by":"publisher","first-page":"277","DOI":"10.32604\/or.2022.027301","volume":"30","author":"F Kong","year":"2022","unstructured":"Kong F, Wu K, Pang L, Huang Y, Li L, Xu J, et al. Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP1. Oncol Res. 2022;30:277\u201388.","journal-title":"Oncol Res"},{"key":"2557_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2675-x","volume":"11","author":"Y Yang","year":"2020","unstructured":"Yang Y, Ma L, Xu Y, Liu Y, Li W, Cai J, et al. Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-kappaB\/STAT3-regulated proteins. Cell Death Dis. 2020;11:477.","journal-title":"Cell Death Dis"},{"key":"2557_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02884-z","volume":"23","author":"M Tsubaki","year":"2023","unstructured":"Tsubaki M, Takeda T, Matsuda T, Kishimoto K, Takefuji H, Taniwaki Y, et al. Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy. Cancer Cell Int. 2023;23:73.","journal-title":"Cancer Cell Int"},{"key":"2557_CR100","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/ijc.32955","volume":"147","author":"FC Franke","year":"2020","unstructured":"Franke FC, Slusarenko BO, Engleitner T, Johannes W, Laschinger M, Rad R, Nitsche U, Janssen KP. Novel role for CRK adaptor proteins as essential components of SRC\/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness. Int J Cancer. 2020;147:1715\u201331.","journal-title":"Int J Cancer"},{"key":"2557_CR101","doi-asserted-by":"crossref","unstructured":"Lopez-Cortes R, Correa Pardo I, Muinelo-Romay L, Fernandez-Briera A, Gil-Martin E. Core fucosylation mediated by the FucT-8 enzyme affects TRAIL-Induced apoptosis and sensitivity to chemotherapy in human SW480 and SW620 colorectal cancer cells. Int J Mol Sci. 2023;24.","DOI":"10.20944\/preprints202306.2147.v1"},{"key":"2557_CR102","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00109-019-01864-z","volume":"98","author":"AU Lindner","year":"2020","unstructured":"Lindner AU, Resler AJ, Carberry S, Oficjalska K, Bacon O, Lee CS, et al. Systems biology analysis identifies molecular determinants of chemotherapy-induced diarrhoea. J Mol Med (Berl). 2020;98:149\u201359.","journal-title":"J Mol Med (Berl)"},{"key":"2557_CR103","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400845","volume":"11","author":"J Li","year":"2024","unstructured":"Li J, Wang Y, Shen W, Zhang Z, Su Z, Guo X, et al. Mitochondria-modulating liposomes reverse radio-resistance for colorectal cancer. Adv Sci. 2024;11:e2400845.","journal-title":"Adv Sci"},{"key":"2557_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105156","volume":"161","author":"TP Khaket","year":"2020","unstructured":"Khaket TP, Singh MP, Khan I, Kang SC. In vitro and in vivo studies on potentiation of curcumin-induced lysosomal-dependent apoptosis upon silencing of cathepsin C in colorectal cancer cells. Pharmacol Res. 2020;161:105156.","journal-title":"Pharmacol Res"},{"key":"2557_CR105","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.7150\/thno.45363","volume":"10","author":"X Song","year":"2020","unstructured":"Song X, Shen L, Tong J, Kuang C, Zeng S, Schoen RE, et al. Mcl-1 inhibition overcomes intrinsic and acquired regorafenib resistance in colorectal cancer. Theranostics. 2020;10:8098\u2013110.","journal-title":"Theranostics"},{"key":"2557_CR106","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2020.10.001","volume":"498","author":"Z Yu","year":"2021","unstructured":"Yu Z, Du J, Zhao Y, Gao Y, Li Y, Zhao K, Lu N. A novel kinase inhibitor, LZT-106, downregulates Mcl-1 and sensitizes colorectal cancer cells to BH3 mimetic ABT-199 by targeting CDK9 and GSK-3beta signaling. Cancer Lett. 2021;498:31\u201341.","journal-title":"Cancer Lett"},{"key":"2557_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2021.104688","volume":"123","author":"N Nazempour","year":"2021","unstructured":"Nazempour N, Taleqani MH, Taheri N, Haji Ali Asgary Najafabadi AH, Shokrollahi A, Zamani A, et al. The role of cell surface proteins gene expression in diagnosis, prognosis, and drug resistance of colorectal cancer: in silico analysis and validation. Exp Mol Pathol. 2021;123:104688.","journal-title":"Exp Mol Pathol"},{"key":"2557_CR108","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.tcb.2022.11.003","volume":"33","author":"H Yan","year":"2023","unstructured":"Yan H, Talty R, Johnson CH. Targeting ferroptosis to treat colorectal cancer. Trends Cell Biol. 2023;33:185\u20138.","journal-title":"Trends Cell Biol"},{"key":"2557_CR109","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s40001-025-02842-7","volume":"30","author":"T Ge","year":"2025","unstructured":"Ge T, Li H, Xiang P, Yang D, Zhou J, Zhang Y. Tanshinone IIA induces ferroptosis in colorectal cancer cells through the suppression of SLC7A11 expression via the PI3K\/AKT\/mTOR pathway. Eur J Med Res. 2025;30:576.","journal-title":"Eur J Med Res"},{"key":"2557_CR110","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gutjnl-2022-327909","volume":"72","author":"C Conche","year":"2023","unstructured":"Conche C, Finkelmeier F, Pesic M, Nicolas AM, Bottger TW, Kennel KB, Denk D, Ceteci F, Mohs K, Engel E, et al. Combining ferroptosis induction with MDSC Blockade renders primary tumours and metastases in liver sensitive to immune checkpoint Blockade. Gut. 2023;72:1774\u201382.","journal-title":"Gut"},{"key":"2557_CR111","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/15548627.2024.2425594","volume":"21","author":"M Arcos","year":"2025","unstructured":"Arcos M, Goodla L, Kim H, Desai SP, Liu R, Yin K, Liu Z, Martin DR, Xue X. PINK1-deficiency facilitates mitochondrial iron accumulation and colon tumorigenesis. Autophagy. 2025;21:737\u201353.","journal-title":"Autophagy"},{"key":"2557_CR112","doi-asserted-by":"crossref","unstructured":"Vuletic A, Mirjacic Martinovic K, Spasic J. Role of histone deacetylase 6 and histone deacetylase 6 Inhibition in colorectal cancer. Pharmaceutics. 2023;16.","DOI":"10.3390\/pharmaceutics16010054"},{"key":"2557_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104693","volume":"109","author":"S Hu","year":"2021","unstructured":"Hu S, Yin J, Yan S, Hu P, Huang J, Zhang G, et al. Chaetocochin J, an epipolythiodioxopiperazine alkaloid, induces apoptosis and autophagy in colorectal cancer via AMPK and PI3K\/AKT\/mTOR pathways. Bioorg Chem. 2021;109:104693.","journal-title":"Bioorg Chem"},{"key":"2557_CR114","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tips.2023.02.003","volume":"44","author":"V Jain","year":"2023","unstructured":"Jain V, Singh MP, Amaravadi RK. Recent advances in targeting autophagy in cancer. Trends Pharmacol Sci. 2023;44:290\u2013302.","journal-title":"Trends Pharmacol Sci"},{"key":"2557_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01322-w","volume":"20","author":"H Chen","year":"2021","unstructured":"Chen H, Yao J, Bao R, Dong Y, Zhang T, Du Y, et al. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer. Mol Cancer. 2021;20:29.","journal-title":"Mol Cancer"},{"key":"2557_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101152","volume":"77","author":"S Luo","year":"2024","unstructured":"Luo S, Yue M, Wang D, Lu Y, Wu Q, Jiang J. Breaking the barrier: epigenetic strategies to combat platinum resistance in colorectal cancer. Drug Resist Updat. 2024;77:101152.","journal-title":"Drug Resist Updat"},{"key":"2557_CR117","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.semcancer.2022.05.012","volume":"86","author":"OA Sukocheva","year":"2022","unstructured":"Sukocheva OA, Liu J, Neganova ME, Beeraka NM, Aleksandrova YR, Manogaran P, Grigorevskikh EM, Chubarev VN, Fan R. Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers. Semin Cancer Biol. 2022;86:358\u201375.","journal-title":"Semin Cancer Biol"},{"key":"2557_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-019-0563-2","volume":"18","author":"G Liang","year":"2020","unstructured":"Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si K, et al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnology. 2020;18:10.","journal-title":"J Nanobiotechnology"},{"key":"2557_CR119","doi-asserted-by":"publisher","first-page":"8271","DOI":"10.1038\/s41598-020-65207-6","volume":"10","author":"LH Sun","year":"2020","unstructured":"Sun LH, Tian D, Yang ZC, Li JL. Exosomal miR-21 promotes proliferation, invasion and therapy resistance of colon adenocarcinoma cells through its target PDCD4. Sci Rep. 2020;10:8271.","journal-title":"Sci Rep"},{"key":"2557_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216364","volume":"573","author":"FF Zhuo","year":"2023","unstructured":"Zhuo FF, Li L, Liu TT, Liang XM, Yang Z, Zheng YZ, et al. Lycorine promotes IDH1 acetylation to induce mitochondrial dynamics imbalance in colorectal cancer cells. Cancer Lett. 2023;573:216364.","journal-title":"Cancer Lett"},{"key":"2557_CR121","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111673","volume":"42","author":"L Wang","year":"2023","unstructured":"Wang L, Wu L, Zhu Z, Zhang Q, Li W, Gonzalez GM, et al. Role of PCIF1-mediated 5\u2019-cap N6-methyladeonsine mRNA methylation in colorectal cancer and anti-PD-1 immunotherapy. EMBO J. 2023;42:e111673.","journal-title":"EMBO J"},{"key":"2557_CR122","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s42255-023-00883-y","volume":"5","author":"C Wang","year":"2023","unstructured":"Wang C, Huang M, Lin Y, Zhang Y, Pan J, Jiang C, et al. ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy. Nat Metab. 2023;5:1765\u201386.","journal-title":"Nat Metab"},{"key":"2557_CR123","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41419-020-02968-y","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, Liu Y, Zhao N, Yang X, Li Y, Zhai F, Zang X, Cui W. Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer. Cell Death Dis. 2020;11:753.","journal-title":"Cell Death Dis"},{"key":"2557_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01555-3","volume":"21","author":"H Liu","year":"2022","unstructured":"Liu H, Li D, Sun L, Qin H, Fan A, Meng L, et al. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m(6)A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression. Mol Cancer. 2022;21:74.","journal-title":"Mol Cancer"},{"key":"2557_CR125","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s13046-021-02143-x","volume":"40","author":"Q Li","year":"2021","unstructured":"Li Q, Sun H, Luo D, Gan L, Mo S, Dai W, Liang L, Yang Y, Xu M, Li J, et al. Lnc-RP11-536 K7.3\/SOX2\/HIF-1alpha signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids. J Exp Clin Cancer Res. 2021;40:348.","journal-title":"J Exp Clin Cancer Res"},{"key":"2557_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01848-1","volume":"22","author":"K Zeng","year":"2023","unstructured":"Zeng K, Peng J, Xing Y, Zhang L, Zeng P, Li W, et al. A positive feedback circuit driven by m(6)A-modified circular RNA facilitates colorectal cancer liver metastasis. Mol Cancer. 2023;22:202.","journal-title":"Mol Cancer"},{"key":"2557_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02052-5","volume":"23","author":"X Jiang","year":"2024","unstructured":"Jiang X, Peng M, Liu Q, Peng Q, Oyang L, Li S, et al. Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation. Mol Cancer. 2024;23:151.","journal-title":"Mol Cancer"},{"key":"2557_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100886","volume":"65","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zheng N, Li J, Li C, Zheng D, Jiang X, et al. N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells. Drug Resist Updat. 2022;65:100886.","journal-title":"Drug Resist Updat"},{"key":"2557_CR129","doi-asserted-by":"crossref","unstructured":"Stein A, Simnica D, Schultheiss C, Scholz R, Tintelnot J, Gokkurt E, von Wenserski L, Willscher E, Paschold L, Sauer M et al. PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer. J Immunother Cancer. 2021;9.","DOI":"10.1136\/jitc-2021-002844"},{"key":"2557_CR130","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.7150\/ijbs.98200","volume":"20","author":"X Zhou","year":"2024","unstructured":"Zhou X, Lin J, Shao Y, Zheng H, Yang Y, Li S, et al. Targeting PLCG2 suppresses tumor progression, orchestrates the tumor immune microenvironment and potentiates immune checkpoint blockade therapy for colorectal cancer. Int J Biol Sci. 2024;20:5548\u201375.","journal-title":"Int J Biol Sci"},{"key":"2557_CR131","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.1038\/s41388-021-01972-6","volume":"40","author":"B Cen","year":"2021","unstructured":"Cen B, Wei J, Wang D, Xiong Y, Shay JW, DuBois RN. Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer. Oncogene. 2021;40:5984\u201392.","journal-title":"Oncogene"},{"key":"2557_CR132","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/10668969211025844","volume":"29","author":"AC Bateman","year":"2021","unstructured":"Bateman AC. Immune checkpoint inhibitor therapy in colorectal cancer-the role of cellular pathology. Int J Surg Pathol. 2021;29:584\u201391.","journal-title":"Int J Surg Pathol"},{"key":"2557_CR133","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.ccell.2021.07.023","volume":"39","author":"Y Wang","year":"2021","unstructured":"Wang Y, Liu S, Yang Z, Algazi AP, Lomeli SH, Wang Y, Othus M, Hong A, Wang X, Randolph CE, et al. Anti-PD-1\/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy. Cancer Cell. 2021;39:1375\u2013e13871376.","journal-title":"Cancer Cell"},{"key":"2557_CR134","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005345","author":"E Kucukkose","year":"2022","unstructured":"Kucukkose E, Heesters BA, Villaudy J, Verheem A, Cercel M, van Hal S, et al. Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1136\/jitc-2022-005345.","journal-title":"J Immunother Cancer"},{"key":"2557_CR135","doi-asserted-by":"publisher","first-page":"e12798","DOI":"10.15252\/emmm.202012798","volume":"13","author":"W Lu","year":"2021","unstructured":"Lu W, Yu W, He J, Liu W, Yang J, Lin X, Zhang Y, Wang X, Jiang W, Luo J, et al. Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer. EMBO Mol Med. 2021;13:e12798.","journal-title":"EMBO Mol Med"},{"key":"2557_CR136","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/s43018-024-00771-8","volume":"5","author":"T Scolaro","year":"2024","unstructured":"Scolaro T, Manco M, Pecqueux M, Amorim R, Trotta R, Van Acker HH, et al. Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance. Nat Cancer. 2024;5:1206\u201326.","journal-title":"Nat Cancer"},{"key":"2557_CR137","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1038\/s44321-024-00105-2","volume":"16","author":"J Deng","year":"2024","unstructured":"Deng J, Pan T, Wang D, Hong Y, Liu Z, Zhou X, et al. The MondoA-dependent TXNIP\/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas. EMBO Mol Med. 2024;16:2080\u2013108.","journal-title":"EMBO Mol Med"},{"key":"2557_CR138","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/s41564-024-01695-w","volume":"9","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wong CC, Ding Y, Gao M, Wen J, Lau HC, et al. Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice. Nat Microbiol. 2024;9:1467\u201382.","journal-title":"Nat Microbiol"},{"key":"2557_CR139","doi-asserted-by":"publisher","first-page":"11080","DOI":"10.7150\/thno.49864","volume":"10","author":"R Cao","year":"2020","unstructured":"Cao R, Yang F, Ma SC, Liu L, Zhao Y, Li Y, et al. Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in colorectal cancer. Theranostics. 2020;10:11080\u201391.","journal-title":"Theranostics"},{"key":"2557_CR140","volume":"1874","author":"DY Lizardo","year":"2020","unstructured":"Lizardo DY, Kuang C, Hao S, Yu J, Huang Y, Zhang L. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside. Biochimica et Biophysica Acta (BBA). 2020;1874:188447.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"2557_CR141","doi-asserted-by":"publisher","first-page":"12153","DOI":"10.1007\/s13277-016-5092-0","volume":"37","author":"H Guan","year":"2016","unstructured":"Guan H, Zhao P, Dai Z, Liu X, Wang X. SH3GL1 inhibition reverses multidrug resistance in colorectal cancer cells by downregulation of MDR1\/P-glycoprotein via EGFR\/ERK\/AP-1 pathway. Tumour Biol. 2016;37:12153\u201360.","journal-title":"Tumour Biol"},{"key":"2557_CR142","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","volume":"41","author":"S Dong","year":"2022","unstructured":"Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L, Zhang W, Li S, Xu Q, Zhong M, et al. ROS\/PI3K\/Akt and Wnt\/beta-catenin signalings activate HIF-1alpha-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer. J Exp Clin Cancer Res. 2022;41:15.","journal-title":"J Exp Clin Cancer Res"},{"key":"2557_CR143","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/gutjnl-2020-323553","volume":"71","author":"LR Mangiapane","year":"2022","unstructured":"Mangiapane LR, Nicotra A, Turdo A, Gaggianesi M, Bianca P, Di Franco S, et al. PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells. Gut. 2022;71:119\u201328.","journal-title":"Gut"},{"key":"2557_CR144","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s41418-020-00692-w","volume":"28","author":"M Haselager","year":"2021","unstructured":"Haselager M, Thijssen R, West C, Young L, Van Kampen R, Willmore E, et al. Regulation of Bcl-XL by non-canonical NF-kappaB in the context of CD40-induced drug resistance in CLL. Cell Death Differ. 2021;28:1658\u201368.","journal-title":"Cell Death Differ"},{"key":"2557_CR145","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1158\/1078-0432.CCR-24-1166","volume":"30","author":"HM Lee","year":"2024","unstructured":"Lee HM, Saw AK, Morris VK, Napolitano S, Bristow C, Srinivasan S, et al. Epigenome reprogramming through H3K27 and H3K4 trimethylation as a resistance mechanism to DNA methylation inhibition in BRAFV600E-mutated colorectal cancer. Clin Cancer Res. 2024;30:5166\u201379.","journal-title":"Clin Cancer Res"},{"key":"2557_CR146","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41575-021-00508-3","volume":"19","author":"TK Lee","year":"2022","unstructured":"Lee TK, Guan XY, Ma S. Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications. Nat Rev Gastroenterol Hepatol. 2022;19:26\u201344.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2557_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00230-7","volume":"5","author":"PS Hu","year":"2020","unstructured":"Hu PS, Li T, Lin JF, Qiu MZ, Wang DS, Liu ZX, et al. VDR-SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment. Signal Transduct Target Ther. 2020;5:183.","journal-title":"Signal Transduct Target Ther"},{"key":"2557_CR148","doi-asserted-by":"publisher","first-page":"e2200364","DOI":"10.1002\/smll.202200364","volume":"18","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang Z, Hu Q, Luo H, Lu B, Gao Y, Qiao Z, Zhou Y, Fang Y, Gu J, et al. 3D bioprinted GelMA-Nanoclay hydrogels induce colorectal cancer stem cells through activating Wnt\/beta-Catenin signaling. Small. 2022;18:e2200364.","journal-title":"Small"},{"key":"2557_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00474-x","volume":"13","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Zong H, Zhu P, Su C, Tang W, Chen Z, et al. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs. Exp Hematol Oncol. 2024;13:6.","journal-title":"Exp Hematol Oncol"},{"key":"2557_CR150","doi-asserted-by":"crossref","unstructured":"Ziranu P, Pretta A, Aimola V, Cau F, Mariani S, D\u2019Agata AP, Codipietro C, Rizzo D, Dell\u2019Utri V, Sanna G et al. CD44: A new prognostic marker in colorectal cancer? Cancers (Basel). 2024;16.","DOI":"10.3390\/cancers16081569"},{"key":"2557_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111364","volume":"137","author":"Z Asadzadeh","year":"2021","unstructured":"Asadzadeh Z, Mansoori B, Mohammadi A, Kazemi T, Mokhtarzadeh A, Shanehbandi D, et al. The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy. Biomed Pharmacother. 2021;137:111364.","journal-title":"Biomed Pharmacother"},{"key":"2557_CR152","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2022.08.028","volume":"163","author":"A Venugopal","year":"2022","unstructured":"Venugopal A, Koi M, Choi C, Kim HR, Speliotes EK, Carethers JM. ALDH1A1 expression is enriched in early-onset colorectal cancers. Gastroenterology. 2022;163:1679-1681 e1671.","journal-title":"Gastroenterology"},{"key":"2557_CR153","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/cac2.12295","volume":"42","author":"AA Bhat","year":"2022","unstructured":"Bhat AA, Nisar S, Singh M, Ashraf B, Masoodi T, Prasad CP, et al. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: emerging avenue for targeted therapy. Cancer Commun. 2022;42:689\u2013715.","journal-title":"Cancer Commun"},{"key":"2557_CR154","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-021-01488-9","volume":"38","author":"X Lei","year":"2021","unstructured":"Lei X, He Q, Li Z, Zou Q, Xu P, Yu H, et al. Cancer stem cells in colorectal cancer and the association with chemotherapy resistance. Med Oncol. 2021;38:43.","journal-title":"Med Oncol"},{"key":"2557_CR155","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.tips.2023.11.006","volume":"45","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang H. Biomarkers and targeted therapy for cancer stem cells. Trends Pharmacol Sci. 2024;45:56\u201366.","journal-title":"Trends Pharmacol Sci"},{"key":"2557_CR156","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1002\/1878-0261.13064","volume":"15","author":"H Yin","year":"2021","unstructured":"Yin H, Gao T, Xie J, Huang Z, Zhang X, Yang F, Qi W, Yang Z, Zhou T, Gao G, Yang X. FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt\/beta-catenin signaling. Mol Oncol. 2021;15:3490\u2013512.","journal-title":"Mol Oncol"},{"key":"2557_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.637298","volume":"11","author":"JGP Sanches","year":"2021","unstructured":"Sanches JGP, Song B, Zhang Q, Cui X, Yabasin IB, Ntim M, et al. The role of KDM2B and EZH2 in regulating the stemness in colorectal cancer through the PI3K\/AKT pathway. Front Oncol. 2021;11:637298.","journal-title":"Front Oncol"},{"key":"2557_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217181","volume":"602","author":"L Zhou","year":"2024","unstructured":"Zhou L, Wen R, Bai C, Li Z, Zheng K, Yu Y, et al. Spatial transcriptomic revealed intratumor heterogeneity and cancer stem cell enrichment in colorectal cancer metastasis. Cancer Lett. 2024;602:217181.","journal-title":"Cancer Lett"},{"key":"2557_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102822","volume":"65","author":"Y He","year":"2023","unstructured":"He Y, Ling Y, Zhang Z, Mertens RT, Cao Q, Xu X, et al. Butyrate reverses ferroptosis resistance in colorectal cancer by inducing c-Fos-dependent xCT suppression. Redox Biol. 2023;65:102822.","journal-title":"Redox Biol"},{"key":"2557_CR160","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13046-021-01934-6","volume":"40","author":"X Liu","year":"2021","unstructured":"Liu X, Su K, Sun X, Jiang Y, Wang L, Hu C, Zhang C, Lu M, Du X, Xing B. Section\u00a062 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt\/beta-catenin pathway. J Exp Clin Cancer Res. 2021;40:132.","journal-title":"J Exp Clin Cancer Res"},{"key":"2557_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417398","author":"A Gisina","year":"2023","unstructured":"Gisina A, Kim Y, Yarygin K, Lupatov A. Can CD133 be regarded as a prognostic biomarker in oncology: pros and cons. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242417398.","journal-title":"Int J Mol Sci"},{"key":"2557_CR162","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301264","volume":"10","author":"C Tang","year":"2023","unstructured":"Tang C, Ke M, Yu X, Sun S, Luo X, Liu X, et al. GART functions as a novel methyltransferase in the RUVBL1\/beta-catenin signaling pathway to promote tumor stemness in colorectal cancer. Adv Sci Weinh. 2023;10:e2301264.","journal-title":"Adv Sci Weinh"},{"key":"2557_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104125","volume":"82","author":"X Zhang","year":"2022","unstructured":"Zhang X, Yang L, Lei W, Hou Q, Huang M, Zhou R, et al. Single-cell sequencing reveals CD133(+)CD44(-)-originating evolution and novel stemness related variants in human colorectal cancer. EBioMedicine. 2022;82:104125.","journal-title":"EBioMedicine"},{"key":"2557_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106618","volume":"85","author":"W Zhang","year":"2020","unstructured":"Zhang W, Chai W, Zhu Z, Li X. Aldehyde oxidase 1 promoted the occurrence and development of colorectal cancer by up-regulation of expression of CD133. Int Immunopharmacol. 2020;85:106618.","journal-title":"Int Immunopharmacol"},{"key":"2557_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01759-6","volume":"9","author":"VR Silva","year":"2023","unstructured":"Silva VR, Santos LS, de Castro MVL, Dias RB, Valverde LF, Rocha CAG, et al. A novel ruthenium complex with 5-fluorouracil suppresses colorectal cancer stem cells by inhibiting Akt\/mTOR signaling. Cell Death Discov. 2023;9:460.","journal-title":"Cell Death Discov"},{"key":"2557_CR166","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1002\/jcb.29600","volume":"121","author":"H Zhao","year":"2020","unstructured":"Zhao H, Chen S, Fu Q. Exosomes from CD133(+) cells carrying circ-ABCC1 mediate cell stemness and metastasis in colorectal cancer. J Cell Biochem. 2020;121:3286\u201397.","journal-title":"J Cell Biochem"},{"key":"2557_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/biom12091256","author":"V Cavallucci","year":"2022","unstructured":"Cavallucci V, Palucci I, Fidaleo M, Mercuri A, Masi L, Emoli V, et al. Proinflammatory and cancer-promoting pathobiont Fusobacterium nucleatum directly targets colorectal cancer stem cells. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12091256.","journal-title":"Biomolecules"},{"key":"2557_CR168","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.7150\/ijbs.58612","volume":"17","author":"J Kim","year":"2021","unstructured":"Kim J, Choi KW, Lee J, Lee J, Lee S, Sun R, et al. Wnt\/beta-catenin signaling inhibitors suppress the tumor-initiating properties of a CD44(+)CD133(+) subpopulation of Caco-2 cells. Int J Biol Sci. 2021;17:1644\u201359.","journal-title":"Int J Biol Sci"},{"key":"2557_CR169","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050819","author":"H Izumi","year":"2023","unstructured":"Izumi H, Kaneko Y, Nakagawara A. Molecular regulation of autophagy and asymmetric cell division by cancer stem cell marker CD133. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12050819.","journal-title":"Cells"},{"key":"2557_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105211","volume":"105","author":"J Na","year":"2024","unstructured":"Na J, Shaji S, Hanemann CO. Targeting histone deacetylase 6 (HDAC6) to enhance radiation therapy in meningiomas in a 2D and 3D in vitro study. EBioMedicine. 2024;105:105211.","journal-title":"EBioMedicine"},{"key":"2557_CR171","doi-asserted-by":"crossref","unstructured":"Sipos F, Muzes G. Interconnection of CD133 stem cell marker with autophagy and apoptosis in colorectal cancer. Int J Mol Sci. 2024;25.","DOI":"10.3390\/ijms252011201"},{"key":"2557_CR172","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201255R","volume":"37","author":"Y Fu","year":"2023","unstructured":"Fu Y, Bai C, Wang S, Chen D, Zhang P, Wei H, et al. AKT1 phosphorylates RBM17 to promote Sox2 transcription by modulating alternative splicing of FOXM1 to enhance cancer stem cell properties in colorectal cancer cells. FASEB J. 2023;37:e22707.","journal-title":"FASEB J"},{"key":"2557_CR173","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/jir.2021.0207","volume":"42","author":"S Guan","year":"2022","unstructured":"Guan S, Yang R, Wu S, Xu K, Yang C. The CD133(+)CXCR4(+) colorectal tumor cells promote colorectal cancer progression by PI3K\/AKT signaling. J Interferon Cytokine Res. 2022;42:195\u2013202.","journal-title":"J Interferon Cytokine Res"},{"key":"2557_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-024-00551-9","volume":"57","author":"C Almarza","year":"2024","unstructured":"Almarza C, Villalobos-Nova K, Toro MA, Gonzalez M, Niechi I, Brown-Brown DA, et al. Cisplatin-resistance and aggressiveness are enhanced by a highly stable endothelin-converting enzyme-1c in lung cancer cells. Biol Res. 2024;57:74.","journal-title":"Biol Res"},{"key":"2557_CR175","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01898-9","volume":"21","author":"E Gheytanchi","year":"2021","unstructured":"Gheytanchi E, Naseri M, Karimi-Busheri F, Atyabi F, Mirsharif ES, Bozorgmehr M, et al. Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines. Cancer Cell Int. 2021;21:204.","journal-title":"Cancer Cell Int"},{"key":"2557_CR176","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113887","author":"YW Eom","year":"2020","unstructured":"Eom YW, Akter R, Li W, Lee S, Hwang S, Kim J, et al. M1 macrophages promote TRAIL expression in adipose tissue-derived stem cells, which suppresses colitis-associated colon cancer by increasing apoptosis of CD133(+) cancer stem cells and decreasing M2 macrophage population. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21113887.","journal-title":"Int J Mol Sci"},{"key":"2557_CR177","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020377","author":"WH Leung","year":"2022","unstructured":"Leung WH, Shih JW, Chen JS, Mokgautsi N, Wei PL, Huang YJ. Preclinical identification of sulfasalazine\u2019s therapeutic potential for suppressing colorectal cancer stemness and metastasis through targeting KRAS\/MMP7\/CD44 signaling. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10020377.","journal-title":"Biomedicines"},{"key":"2557_CR178","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.ccell.2023.07.012","volume":"41","author":"Q Huang","year":"2023","unstructured":"Huang Q, Liu L, Xiao D, Huang Z, Wang W, Zhai K, Fang X, Kim J, Liu J, Liang W, et al. CD44(+) lung cancer stem cell-derived pericyte-like cells cause brain metastases through GPR124-enhanced trans-endothelial migration. Cancer Cell. 2023;41:1621\u2013e16361628.","journal-title":"Cancer Cell"},{"key":"2557_CR179","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01156-y","volume":"19","author":"R Pothuraju","year":"2020","unstructured":"Pothuraju R, Rachagani S, Krishn SR, Chaudhary S, Nimmakayala RK, Siddiqui JA, et al. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance. Mol Cancer. 2020;19:37.","journal-title":"Mol Cancer"},{"key":"2557_CR180","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.tem.2022.02.002","volume":"33","author":"X Weng","year":"2022","unstructured":"Weng X, Maxwell-Warburton S, Hasib A, Ma L, Kang L. The membrane receptor CD44: novel insights into metabolism. Trends Endocrinol Metab. 2022;33:318\u201332.","journal-title":"Trends Endocrinol Metab"},{"key":"2557_CR181","doi-asserted-by":"publisher","DOI":"10.3390\/biom10111525","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Chanmee T, Itano N. Hyaluronan: metabolism and function. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10111525.","journal-title":"Biomolecules"},{"key":"2557_CR182","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/imr.13081","volume":"311","author":"A Yim","year":"2022","unstructured":"Yim A, Smith C, Brown AM. Osteopontin\/secreted phosphoprotein-1 harnesses glial-, immune-, and neuronal cell ligand-receptor interactions to sense and regulate acute and chronic neuroinflammation. Immunol Rev. 2022;311:224\u201333.","journal-title":"Immunol Rev"},{"key":"2557_CR183","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-212","volume":"9","author":"SS Kanwar","year":"2010","unstructured":"Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar AP. The Wnt\/beta-catenin pathway regulates growth and maintenance of colonospheres. Mol Cancer. 2010;9:212.","journal-title":"Mol Cancer"},{"key":"2557_CR184","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/cdd.2014.156","volume":"22","author":"M Schmitt","year":"2015","unstructured":"Schmitt M, Metzger M, Gradl D, Davidson G, Orian-Rousseau V. CD44 functions in Wnt signaling by regulating LRP6 localization and activation. Cell Death Differ. 2015;22:677\u201389.","journal-title":"Cell Death Differ"},{"key":"2557_CR185","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1405-7","volume":"38","author":"SY Park","year":"2019","unstructured":"Park SY, Lee CJ, Choi JH, Kim JH, Kim JW, Kim JY, et al. The JAK2\/STAT3\/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance. J Exp Clin Cancer Res. 2019;38:399.","journal-title":"J Exp Clin Cancer Res"},{"key":"2557_CR186","doi-asserted-by":"publisher","DOI":"10.3390\/cells13110930","author":"L Ng","year":"2024","unstructured":"Ng L, Wong SK, Li HS, Sin RW, Man JH, Lo OS, et al. A four-gene panel in rectal swab samples as a biomarker for colorectal cancer screening. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13110930.","journal-title":"Cells"},{"key":"2557_CR187","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.906260","volume":"12","author":"S Ghatak","year":"2022","unstructured":"Ghatak S, Hascall VC, Karamanos N, Markwald RR, Misra S. Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through beta-catenin\/MDR1 signaling to sustain chemoresistance. Front Oncol. 2022;12:906260.","journal-title":"Front Oncol"},{"key":"2557_CR188","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194966","author":"G Belthier","year":"2021","unstructured":"Belthier G, Homayed Z, Grillet F, Duperray C, Vendrell J, Krol I, et al. CD44v6 defines a new population of circulating tumor cells not expressing EpCAM. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13194966.","journal-title":"Cancers (Basel)"},{"key":"2557_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.869485","volume":"12","author":"ML De Angelis","year":"2022","unstructured":"De Angelis ML, Francescangeli F, Nicolazzo C, Xhelili E, La Torre F, Colace L, et al. An orthotopic patient-derived xenograft (PDX) model allows the analysis of metastasis-associated features in colorectal cancer. Front Oncol. 2022;12:869485.","journal-title":"Front Oncol"},{"key":"2557_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/cells13211802","author":"A Muller","year":"2024","unstructured":"Muller A, Lyubarskyy B, Tchoumakov J, Wagner M, Sprang B, Ringel F, et al. ALDH1A3 contributes to radiation-induced inhibition of self-renewal and promotes proliferative activity of p53-deficient glioblastoma stem cells at the onset of differentiation. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13211802.","journal-title":"Cells"},{"key":"2557_CR191","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1026278","volume":"12","author":"Y Wei","year":"2022","unstructured":"Wei Y, Li Y, Chen Y, Liu P, Huang S, Zhang Y, et al. ALDH1: a potential therapeutic target for cancer stem cells in solid tumors. Front Oncol. 2022;12:1026278.","journal-title":"Front Oncol"},{"key":"2557_CR192","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.21873\/anticanres.15294","volume":"41","author":"S Miyamoto","year":"2021","unstructured":"Miyamoto S, Fukui T, Horitani S, Tanimura Y, Matsumoto Y, Suzuki R, et al. Linker threonine-phosphorylated Smad2\/3 is a biomarker of colorectal neoplastic stem-like cells that correlates with carcinogenesis. Anticancer Res. 2021;41:4789\u201399.","journal-title":"Anticancer Res"},{"key":"2557_CR193","doi-asserted-by":"publisher","first-page":"10830","DOI":"10.1111\/jcmm.15708","volume":"24","author":"C Yang","year":"2020","unstructured":"Yang C, Shi S, Su Y, Tong JS, Li L. P2X7R promotes angiogenesis and tumour-associated macrophage recruitment by regulating the NF-kappaB signalling pathway in colorectal cancer cells. J Cell Mol Med. 2020;24:10830\u201341.","journal-title":"J Cell Mol Med"},{"key":"2557_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03164-8","volume":"11","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Hu H, Yuan Z, Zhang Q, Xiong H, Hu Z, et al. LncRNA NEAT1 remodels chromatin to promote the 5-Fu resistance by maintaining colorectal cancer stemness. Cell Death Dis. 2020;11:962.","journal-title":"Cell Death Dis"},{"key":"2557_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101025","volume":"14","author":"L MacDonagh","year":"2021","unstructured":"MacDonagh L, Santiago RM, Gray SG, Breen E, Cuffe S, Finn SP, et al. Exploitation of the vitamin A\/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin. Transl Oncol. 2021;14:101025.","journal-title":"Transl Oncol"},{"key":"2557_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111077","volume":"40","author":"J Kim","year":"2022","unstructured":"Kim J, Park A, Hwang J, Zhao X, Kwak J, Kim HW, et al. KS10076, a chelator for redox-active metal ions, induces ROS-mediated STAT3 degradation in autophagic cell death and eliminates ALDH1(+) stem cells. Cell Rep. 2022;40:111077.","journal-title":"Cell Rep"},{"key":"2557_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114213","volume":"442","author":"N Datta","year":"2024","unstructured":"Datta N, Vp S, Parvathy K, A SS, Maliekal TT. ALDH1A1 as a marker for metastasis initiating cells: a mechanistic insight. Exp Cell Res. 2024;442:114213.","journal-title":"Exp Cell Res"},{"key":"2557_CR198","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03118-4","volume":"43","author":"F Gao","year":"2024","unstructured":"Gao F, Liu S, Wang J, Wei G, Yu C, Zheng L, et al. TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110alpha mediated activation of AKT signaling pathway. J Exp Clin Cancer Res. 2024;43:201.","journal-title":"J Exp Clin Cancer Res"},{"key":"2557_CR199","first-page":"636","volume":"21","author":"S Crunkhorn","year":"2022","unstructured":"Crunkhorn S. Targeting ALDH1B1 in colorectal cancer. Nat Rev Drug Discov. 2022;21:636.","journal-title":"Nat Rev Drug Discov"},{"key":"2557_CR200","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41589-022-01048-w","volume":"18","author":"Z Feng","year":"2022","unstructured":"Feng Z, Hom ME, Bearrood TE, Rosenthal ZC, Fernandez D, Ondrus AE, et al. Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1. Nat Chem Biol. 2022;18:1065\u201375.","journal-title":"Nat Chem Biol"},{"key":"2557_CR201","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/s44321-024-00121-2","volume":"16","author":"HC Chen","year":"2024","unstructured":"Chen HC, Mueller N, Stott K, Kapeni C, Rivers E, Sauer CM, Beke F, Walsh SJ, Ashman N, O\u2019Brien L, et al. Novel immunotherapeutics against LGR5 to target multiple cancer types. EMBO Mol Med. 2024;16:2233\u201361.","journal-title":"EMBO Mol Med"},{"key":"2557_CR202","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/hep.32328","volume":"76","author":"S Annunziato","year":"2022","unstructured":"Annunziato S, Sun T, Tchorz JS. The RSPO-LGR4\/5-ZNRF3\/RNF43 module in liver homeostasis, regeneration, and disease. Hepatology. 2022;76:888\u201399.","journal-title":"Hepatology"},{"key":"2557_CR203","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stem.2020.02.008","volume":"26","author":"A Fumagalli","year":"2020","unstructured":"Fumagalli A, Oost KC, Kester L, Morgner J, Bornes L, Bruens L, Spaargaren L, Azkanaz M, Schelfhorst T, Beerling E, et al. Plasticity of Lgr5-Negative cancer cells drives metastasis in colorectal cancer. Cell Stem Cell. 2020;26:569\u2013e578567.","journal-title":"Cell Stem Cell"},{"key":"2557_CR204","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-022-05402-9","volume":"611","author":"A Canellas-Socias","year":"2022","unstructured":"Canellas-Socias A, Cortina C, Hernando-Momblona X, Palomo-Ponce S, Mulholland EJ, Turon G, et al. Metastatic recurrence in colorectal cancer arises from residual EMP1(+) cells. Nature. 2022;611:603\u201313.","journal-title":"Nature"},{"key":"2557_CR205","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02401-6","volume":"41","author":"B Liu","year":"2022","unstructured":"Liu B, Fang X, Kwong DL, Zhang Y, Verhoeft K, Gong L, et al. Targeting TROY-mediated P85a\/AKT\/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41:182.","journal-title":"J Exp Clin Cancer Res"},{"key":"2557_CR206","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41419-021-03733-5","volume":"12","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Huang S, Chen S, Chen J, Wang Z, Wang Y, Zheng H. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by beta-catenin and Beclin1\/autophagy signaling in colorectal cancer. Cell Death Dis. 2021;12:449.","journal-title":"Cell Death Dis"},{"key":"2557_CR207","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12808","volume":"73","author":"D Sokolov","year":"2022","unstructured":"Sokolov D, Sharda N, Giri B, Hassan MS, Singh D, Tarasiewicz A, et al. Melatonin and andrographolide synergize to inhibit the colospheroid phenotype by targeting Wnt\/beta-catenin signaling. J Pineal Res. 2022;73:e12808.","journal-title":"J Pineal Res"},{"key":"2557_CR208","doi-asserted-by":"publisher","DOI":"10.3390\/nu15112447","author":"TY Huang","year":"2023","unstructured":"Huang TY, Yang CK, Chen MY, Yadav VK, Fong IH, Yeh CT, et al. Furanocoumarin notopterol: inhibition of hepatocellular carcinogenesis through suppression of cancer stemness signaling and induction of oxidative stress-associated cell death. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15112447.","journal-title":"Nutrients"},{"key":"2557_CR209","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13046-021-02147-7","volume":"40","author":"Y Lee","year":"2021","unstructured":"Lee Y, Yoon J, Ko D, Yu M, Lee S, Kim S. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1. J Exp Clin Cancer Res. 2021;40:372.","journal-title":"J Exp Clin Cancer Res"},{"key":"2557_CR210","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010609","author":"JW Shih","year":"2024","unstructured":"Shih JW, Wu ATH, Mokgautsi N, Wei PL, Huang YJ. Preclinical repurposing of sitagliptin as a drug candidate for colorectal cancer by targeting CD24\/CTNNB1\/SOX4-centered signaling hub. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25010609.","journal-title":"Int J Mol Sci"},{"key":"2557_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110557","volume":"121","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yu H, Yu M, Liu H, Zhang B, Wang Y, et al. CD24 blockade as a novel strategy for cancer treatment. Int Immunopharmacol. 2023;121:110557.","journal-title":"Int Immunopharmacol"},{"key":"2557_CR212","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713179","author":"F Lasorsa","year":"2023","unstructured":"Lasorsa F, Rutigliano M, Milella M, Ferro M, Pandolfo SD, Crocetto F, et al. Cancer stem cells in renal cell carcinoma: origins and biomarkers. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241713179.","journal-title":"Int J Mol Sci"},{"key":"2557_CR213","first-page":"5141","volume":"11","author":"JL Huang","year":"2021","unstructured":"Huang JL, Oshi M, Endo I, Takabe K. Clinical relevance of stem cell surface markers CD133, CD24, and CD44 in colorectal cancer. Am J Cancer Res. 2021;11:5141\u201354.","journal-title":"Am J Cancer Res"},{"key":"2557_CR214","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/JCMA.0000000000000282","volume":"83","author":"JL Chen","year":"2020","unstructured":"Chen JL, Tseng LM. The role of CD24\u2009+\u2009population in non-cancer stem cells. J Chin Med Assoc. 2020;83:321\u20132.","journal-title":"J Chin Med Assoc"},{"key":"2557_CR215","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-0042-1743569","volume":"9","author":"L Huang","year":"2022","unstructured":"Huang L, Ding Z, Zhang Y. CD24 (+) MDSC-DCs induced by CCL5-deficiency showed improved antitumor activity as tumor vaccines. Glob Med Genet. 2022;9:97\u2013109.","journal-title":"Glob Med Genet"},{"key":"2557_CR216","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1158\/0008-5472.CAN-19-3188","volume":"80","author":"TW Wang","year":"2020","unstructured":"Wang TW, Chern E, Hsu CW, Tseng KC, Chao HM. SIRT1-mediated expression of CD24 and epigenetic suppression of novel tumor suppressor miR-1185-1 increases colorectal cancer stemness. Cancer Res. 2020;80:5257\u201369.","journal-title":"Cancer Res"},{"key":"2557_CR217","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2022.102598","volume":"46","author":"AF Farag","year":"2022","unstructured":"Farag AF, Hassabou NF. CD24-gold nanocomposite as promising and sensitive biomarker for cancer stem cells in salivary gland tumors. Nanomedicine. 2022;46:102598.","journal-title":"Nanomedicine"},{"key":"2557_CR218","doi-asserted-by":"publisher","first-page":"e2306535","DOI":"10.1002\/advs.202306535","volume":"11","author":"B Li","year":"2024","unstructured":"Li B, Ming H, Qin S, Zhou L, Huang Z, Jin P, Peng L, Luo M, Zhang T, Wang K, et al. HSPA8 activates Wnt\/beta-Catenin signaling to facilitate BRAF V600E colorectal cancer progression by CMA-Mediated CAV1 degradation. Adv Sci (Weinh). 2024;11:e2306535.","journal-title":"Adv Sci (Weinh)"},{"key":"2557_CR219","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1158\/1541-7786.MCR-20-0867","volume":"19","author":"AC Beck","year":"2021","unstructured":"Beck AC, Cho E, White JR, Paemka L, Li T, Gu VW, Thompson DT, Koch KE, Franke C, Gosse M, et al. AP-2alpha regulates S-Phase and is a marker for sensitivity to PI3K inhibitor buparlisib in colon cancer. Mol Cancer Res. 2021;19:1156\u201367.","journal-title":"Mol Cancer Res"},{"key":"2557_CR220","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s10637-019-00814-3","volume":"38","author":"R Goodwin","year":"2020","unstructured":"Goodwin R, Jonker D, Chen E, Kennecke H, Cabanero M, Tsao MS, et al. A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancer. Invest New Drugs. 2020;38:1077\u201384.","journal-title":"Invest New Drugs"},{"key":"2557_CR221","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cac2.12138","volume":"41","author":"G Pan","year":"2021","unstructured":"Pan G, Liu Y, Shang L, Zhou F, Yang S. EMT-associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Commun (Lond). 2021;41:199\u2013217.","journal-title":"Cancer Commun (Lond)"},{"key":"2557_CR222","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02593-8","volume":"11","author":"F Nie","year":"2025","unstructured":"Nie F, Sun X, Sun J, Zhang J, Wang Y. Epithelial-mesenchymal transition in colorectal cancer metastasis and progression: molecular mechanisms and therapeutic strategies. Cell Death Discov. 2025;11:336.","journal-title":"Cell Death Discov"},{"key":"2557_CR223","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26167743","author":"V Arre","year":"2025","unstructured":"Arre V, Scavo MP, Donghia R, Dituri F, Mandorino C, Cassotta M, et al. Inorganic polyphosphate triggers NLRP3 inflammasome and promotes the epithelial-to-mesenchymal transition and migration of colorectal cancer cells through TRPM8 receptor. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26167743.","journal-title":"Int J Mol Sci"},{"key":"2557_CR224","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202509861","author":"J Zhou","year":"2025","unstructured":"Zhou J, Qiu S, Yang X, Wu Y, Yao X, Hu H, et al. Hypoxia-induced PRMT1 lactylation drives vimentin arginine asymmetric dimethylation in tumor metastasis. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202509861.","journal-title":"Adv Sci"},{"key":"2557_CR225","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","volume":"21","author":"AW Lambert","year":"2021","unstructured":"Lambert AW, Weinberg RA. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat Rev Cancer. 2021;21:325\u201338.","journal-title":"Nat Rev Cancer"},{"key":"2557_CR226","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-023-02791-w","volume":"30","author":"K Shitara","year":"2024","unstructured":"Shitara K, Muro K, Watanabe J, Yamazaki K, Ohori H, Shiozawa M, et al. Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer. Nat Med. 2024;30:730\u20139.","journal-title":"Nat Med"},{"key":"2557_CR227","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canlet.2020.01.008","volume":"474","author":"E Abad","year":"2020","unstructured":"Abad E, Graifer D, Lyakhovich A. DNA damage response and resistance of cancer stem cells. Cancer Lett. 2020;474:106\u201317.","journal-title":"Cancer Lett"},{"key":"2557_CR228","doi-asserted-by":"crossref","unstructured":"Sawai K, Koneri K, Kimura Y, Goi T. CD133 expression in Circulating tumor cells as a prognostic marker in colorectal cancer. Int J Mol Sci. 2025;26.","DOI":"10.20944\/preprints202504.1362.v1"},{"key":"2557_CR229","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1552665","volume":"16","author":"D Maltseva","year":"2025","unstructured":"Maltseva D, Zhiyanov A, Lange T, Tonevitsky A. CD44 knockdown alters miRNA expression and their target genes in colon cancer. Front Immunol. 2025;16:1552665.","journal-title":"Front Immunol"},{"key":"2557_CR230","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jare.2023.12.013","volume":"65","author":"Y Vijayan","year":"2024","unstructured":"Vijayan Y, James S, Viswanathan A, Aparna JS, Bindu A, Namitha NN, Anantharaman D, Babu Lankadasari M, Harikumar KB. Targeting acid ceramidase enhances antitumor immune response in colorectal cancer. J Adv Res. 2024;65:73\u201387.","journal-title":"J Adv Res"},{"key":"2557_CR231","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2508949","volume":"17","author":"S Zhou","year":"2025","unstructured":"Zhou S, Wang K, Huang J, Xu Z, Yuan Q, Liu L, et al. Indole-3-lactic acid suppresses colorectal cancer via metabolic reprogramming. Gut Microbes. 2025;17:2508949.","journal-title":"Gut Microbes"},{"key":"2557_CR232","doi-asserted-by":"publisher","first-page":"5993","DOI":"10.1038\/s41388-021-01962-8","volume":"40","author":"G Yang","year":"2021","unstructured":"Yang G, Huang L, Jia H, Aikemu B, Zhang S, Shao Y, et al. NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer. Oncogene. 2021;40:5993\u20136006.","journal-title":"Oncogene"},{"key":"2557_CR233","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.7150\/ijbs.88779","volume":"20","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Kuang Y, Wang C, Yu Y, Pan L, Hu X. Impact of KRAS mutation on the tumor microenvironment in colorectal cancer. Int J Biol Sci. 2024;20:1947\u201364.","journal-title":"Int J Biol Sci"},{"key":"2557_CR234","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/s41591-024-02813-1","volume":"30","author":"F Wang","year":"2024","unstructured":"Wang F, Jin Y, Wang M, Luo HY, Fang WJ, Wang YN, et al. Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS\/pMMR colorectal cancer: a randomized phase 2 trial. Nat Med. 2024;30:1035\u201343.","journal-title":"Nat Med"},{"key":"2557_CR235","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41419-021-03572-4","volume":"12","author":"M Lepore Signorile","year":"2021","unstructured":"Lepore Signorile M, Grossi V, Di Franco S, Forte G, Disciglio V, Fasano C, Sanese P, De Marco K, Susca FC, Mangiapane LR, et al. Pharmacological targeting of the novel beta-catenin chromatin-associated kinase p38alpha in colorectal cancer stem cell tumorspheres and organoids. Cell Death Dis. 2021;12:316.","journal-title":"Cell Death Dis"},{"key":"2557_CR236","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02192-8","volume":"23","author":"Y Hu","year":"2024","unstructured":"Hu Y, Cai ZR, Huang RZ, Wang DS, Ju HQ, Chen DL. Circular RNA circPHLPP2 promotes tumor growth and anti-PD-1 resistance through binding ILF3 to regulate IL36gamma transcription in colorectal cancer. Mol Cancer. 2024;23:272.","journal-title":"Mol Cancer"},{"key":"2557_CR237","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010639","author":"J Duan","year":"2025","unstructured":"Duan J, Chen T, Li Q, Zhang Y, Lu T, Xue J, et al. Protein arginine methyltransferase 6 enhances immune checkpoint blockade efficacy via the STING pathway in MMR-proficient colorectal cancer. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2024-010639.","journal-title":"J Immunother Cancer"},{"key":"2557_CR238","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03173-x","volume":"43","author":"V Benboubker","year":"2024","unstructured":"Benboubker V, Ramzy GM, Jacobs S, Nowak-Sliwinska P. Challenges in validation of combination treatment strategies for CRC using patient-derived organoids. J Exp Clin Cancer Res. 2024;43:259.","journal-title":"J Exp Clin Cancer Res"},{"key":"2557_CR239","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101311","volume":"4","author":"Y Li","year":"2023","unstructured":"Li Y, Wang B, Ma F, Jiang D, Wang Y, Li K, et al. Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies. Cell Rep Med. 2023;4:101311.","journal-title":"Cell Rep Med"},{"key":"2557_CR240","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41588-024-02058-1","volume":"57","author":"S Mzoughi","year":"2025","unstructured":"Mzoughi S, Schwarz M, Wang X, Demircioglu D, Ulukaya G, Mohammed K, et al. Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer. Nat Genet. 2025;57:402\u201312.","journal-title":"Nat Genet"},{"key":"2557_CR241","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154524","volume":"108","author":"W Liao","year":"2023","unstructured":"Liao W, Zhang L, Chen X, Xiang J, Zheng Q, Chen N, et al. Targeting cancer stem cells and signalling pathways through phytochemicals: a promising approach against colorectal cancer. Phytomedicine. 2023;108:154524.","journal-title":"Phytomedicine"},{"key":"2557_CR242","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1038\/s41467-020-19173-2","volume":"11","author":"YH Cho","year":"2020","unstructured":"Cho YH, Ro EJ, Yoon JS, Mizutani T, Kang DW, Park JC, Il Kim T, Clevers H, Choi KY. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT\/beta-catenin pathway activation. Nat Commun. 2020;11:5321.","journal-title":"Nat Commun"},{"key":"2557_CR243","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41416-021-01389-8","volume":"125","author":"J Rodon","year":"2021","unstructured":"Rodon J, Argiles G, Connolly RM, Vaishampayan U, de Jonge M, Garralda E, et al. Phase 1 study of single-agent WNT974, a first-in-class porcupine inhibitor, in patients with advanced solid tumours. Br J Cancer. 2021;125:28\u201337.","journal-title":"Br J Cancer"},{"key":"2557_CR244","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1158\/1078-0432.CCR-21-3874","volume":"28","author":"MM Gounder","year":"2022","unstructured":"Gounder MM, Rosenbaum E, Wu N, Dickson MA, Sheikh TN, D\u2019Angelo SP, et al. A phase Ib\/II randomized study of RO4929097, a gamma-secretase or notch inhibitor with or without vismodegib, a hedgehog inhibitor, in advanced sarcoma. Clin Cancer Res. 2022;28:1586\u201394.","journal-title":"Clin Cancer Res"},{"key":"2557_CR245","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.3390\/curroncol28050312","volume":"28","author":"D Chan","year":"2021","unstructured":"Chan D, Kaplan J, Gordon G, Desai J. Activity of the gamma secretase inhibitor AL101 in desmoid tumors: a case report of 2 adult cases. Curr Oncol. 2021;28:3659\u201367.","journal-title":"Curr Oncol"},{"key":"2557_CR246","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41419-024-06680-z","volume":"15","author":"P Bustamante-Madrid","year":"2024","unstructured":"Bustamante-Madrid P, Barbachano A, Albandea-Rodriguez D, Rodriguez-Cobos J, Rodriguez-Salas N, Prieto I, Burgos A, Martinez de Villarreal J, Real FX, Gonzalez-Sancho JM, et al. Vitamin D opposes multilineage cell differentiation induced by Notch Inhibition and BMP4 pathway activation in human colon organoids. Cell Death Dis. 2024;15:301.","journal-title":"Cell Death Dis"},{"key":"2557_CR247","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115369","volume":"254","author":"D Zhou","year":"2023","unstructured":"Zhou D, Xu Z, Huang Y, Wang H, Zhu X, Zhang W, et al. Structure-based discovery of potent USP28 inhibitors derived from Vismodegib. Eur J Med Chem. 2023;254:115369.","journal-title":"Eur J Med Chem"},{"key":"2557_CR248","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155357","volume":"258","author":"J Li","year":"2024","unstructured":"Li J, Li J, Chen J, Cao W, Chen B. Comprehensive analysis of ATP6V1s family member, ATP6V1C2, with prognostic and drug development values in colorectal cancer. Pathol Res Pract. 2024;258:155357.","journal-title":"Pathol Res Pract"},{"key":"2557_CR249","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114230","volume":"387","author":"Y Wang","year":"2025","unstructured":"Wang Y, Cheng W, Chen Y, Tian H, Huang C, Li K. Endoplasmic reticulum-mitochondria dual-targeting nanoplatform suppresses cancer stemness and enhances colorectal cancer immunotherapy. J Control Release. 2025;387:114230.","journal-title":"J Control Release"},{"key":"2557_CR250","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1846926","volume":"9","author":"H Dai","year":"2020","unstructured":"Dai H, Tong C, Shi D, Chen M, Guo Y, Chen D, et al. Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial. Oncoimmunology. 2020;9:1846926.","journal-title":"Oncoimmunology"},{"key":"2557_CR251","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202102051","volume":"8","author":"H Kong","year":"2021","unstructured":"Kong H, Ju E, Yi K, Xu W, Lao YH, Cheng D, et al. Advanced nanotheranostics of CRISPR\/Cas for viral hepatitis and hepatocellular carcinoma. Adv Sci. 2021;8:2102051.","journal-title":"Adv Sci"},{"key":"2557_CR252","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s43018-023-00588-x","volume":"4","author":"A Peri","year":"2023","unstructured":"Peri A, Salomon N, Wolf Y, Kreiter S, Diken M, Samuels YJNc. The landscape of T cell antigens for cancer immunotherapy. Nat Cancer. 2023;4:937\u201354.","journal-title":"Nat Cancer"},{"key":"2557_CR253","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01748-4","volume":"22","author":"B Wu","year":"2023","unstructured":"Wu B, Shi X, Jiang M, Liu HJMC. Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment. Mol Cancer. 2023;22:38.","journal-title":"Mol Cancer"},{"key":"2557_CR254","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"CC Wong","year":"2023","unstructured":"Wong CC, Yu J. Gut microbiota in colorectal cancer development and therapy. Nat Rev Clin Oncol. 2023;20:429\u201352.","journal-title":"Nat Rev Clin Oncol"},{"key":"2557_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215816","volume":"545","author":"W Zhao","year":"2022","unstructured":"Zhao W, Jin L, Chen P, Li D, Gao W, Dong G. Colorectal cancer immunotherapy-recent progress and future directions. Cancer Lett. 2022;545:215816.","journal-title":"Cancer Lett"},{"key":"2557_CR256","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202407191","volume":"21","author":"M Zhou","year":"2025","unstructured":"Zhou M, Niu H, Huang G, Zhou M, Cui D, Li H, et al. Biomimetic nano-delivery of small-molecule piceatannol modulates tumor stemness and suppresses colorectal cancer metastasis via Hippo\/YAP1\/SOX9 signaling. Small. 2025;21:e2407191.","journal-title":"Small"},{"key":"2557_CR257","doi-asserted-by":"publisher","first-page":"12628","DOI":"10.1021\/acs.analchem.1c02335","volume":"93","author":"D Lin","year":"2021","unstructured":"Lin D, Chen X, Liu Y, Lin Z, Luo Y, Fu M, et al. Microgel single-cell culture arrays on a microfluidic chip for selective expansion and recovery of colorectal cancer stem cells. Anal Chem. 2021;93:12628\u201338.","journal-title":"Anal Chem"},{"key":"2557_CR258","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.7150\/thno.88864","volume":"14","author":"K Onyshchenko","year":"2024","unstructured":"Onyshchenko K, Luo R, Rao X, Zhang X, Gaedicke S, Grosu AL, et al. Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor models. Theranostics. 2024;14:2573\u201388.","journal-title":"Theranostics"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02557-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T11:45:28Z","timestamp":1772451928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-025-02557-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":258,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2557"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02557-7","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Delcarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}